• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者对电子通讯和患者报告结局数据采集的看法:一项定性研究。

Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study.

机构信息

Weill Cornell Medical College and the Hospital for Special Surgery, New York, New York.

University of Alabama at Birmingham.

出版信息

Arthritis Care Res (Hoboken). 2019 Jan;71(1):80-87. doi: 10.1002/acr.23580.

DOI:10.1002/acr.23580
PMID:29669191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6388703/
Abstract

OBJECTIVE

To identify the perspectives of patients with rheumatoid arthritis (RA) on electronic recording of between-visit disease activity and other patient-reported outcomes (PROs) and on sharing this information with health care providers or peers.

METHODS

Patients with RA were recruited to participate in focus groups from December 2014 to April 2015. The topic guide and analysis were based on the Andersen-Newman framework. Sessions were audiorecorded, transcribed, independently coded, and analyzed for themes.

RESULTS

Thirty-one patients participated in 7 focus groups. Their mean ± SD age was 51 ± 13.1 years, 94% were women, 52% were African American, 11% were Hispanic, and 37% were white. Three themes emerged: provider communication, information-seeking about RA, and social and peer support. Participants expressed a willingness to track disease activity data to share with health care providers electronically if providers would act on the information. Participants envisioned symptom tracking and information sharing as a mechanism to relay and obtain reliable information about RA. Participants were also interested in electronic communication between visits if it facilitated learning about symptom management and enhanced opportunities for social support among patients with RA.

CONCLUSION

Patients with RA may be amenable to electronic collection and sharing of PRO-type data between clinical encounters if it facilitates communication with health care providers and provides access to reliable information about RA. Providing patients with social support was important for enhancing PROs collection by helping them overcome barriers by using electronic devices and overcome reservations about the value of these data.

摘要

目的

确定类风湿关节炎(RA)患者对就诊间疾病活动度和其他患者报告结局(PRO)的电子记录以及与医疗保健提供者或同行共享这些信息的看法。

方法

从 2014 年 12 月至 2015 年 4 月,招募 RA 患者参加焦点小组。主题指南和分析基于安德森-纽曼框架。会议进行了录音、转录、独立编码和主题分析。

结果

31 名患者参加了 7 个焦点小组。他们的平均年龄±SD 为 51±13.1 岁,94%为女性,52%为非裔美国人,11%为西班牙裔,37%为白人。出现了三个主题:提供者沟通、对 RA 的信息寻求以及社会和同伴支持。参与者表示,如果提供者会对信息采取行动,他们愿意通过电子方式跟踪疾病活动数据并与医疗保健提供者共享。参与者设想症状跟踪和信息共享是一种传递和获取有关 RA 的可靠信息的机制。如果电子通信可以促进症状管理的学习并为 RA 患者提供更多的社交支持机会,参与者也对就诊间的电子通信感兴趣。

结论

如果电子收集和共享 PRO 型数据有助于与医疗保健提供者进行沟通并提供有关 RA 的可靠信息,RA 患者可能会接受就诊间的电子收集和共享。为患者提供社交支持对于通过帮助他们克服使用电子设备的障碍和克服对这些数据价值的保留意见来增强 PRO 数据的收集非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ec/6388703/fce60a3e9ddf/nihms-960497-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ec/6388703/9a21bff21b72/nihms-960497-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ec/6388703/fce60a3e9ddf/nihms-960497-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ec/6388703/9a21bff21b72/nihms-960497-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ec/6388703/fce60a3e9ddf/nihms-960497-f0002.jpg

相似文献

1
Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study.类风湿关节炎患者对电子通讯和患者报告结局数据采集的看法:一项定性研究。
Arthritis Care Res (Hoboken). 2019 Jan;71(1):80-87. doi: 10.1002/acr.23580.
2
Using the technology acceptance model to assess clinician perceptions and experiences with a rheumatoid arthritis outcomes dashboard: qualitative study.利用技术接受模型评估临床医生对类风湿关节炎结果仪表板的看法和体验:定性研究。
BMC Med Inform Decis Mak. 2024 May 27;24(1):140. doi: 10.1186/s12911-024-02530-2.
3
Patient-reported outcomes in RA care improve patient communication, decision-making, satisfaction and confidence: qualitative results.类风湿关节炎护理中的患者报告结局可改善患者沟通、决策、满意度和信心:定性结果。
Rheumatology (Oxford). 2020 Jul 1;59(7):1662-1670. doi: 10.1093/rheumatology/kez506.
4
Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation.在类风湿关节炎随机对照试验中使用每日电子患者报告结局(PRO)日记:基本原理与实施
Trials. 2019 Mar 22;20(1):182. doi: 10.1186/s13063-019-3272-0.
5
Patient perceptions of an electronic-health-record-based rheumatoid arthritis outcomes dashboard: a mixed-methods study.基于电子病历的类风湿关节炎结果数据仪表盘的患者感知:一项混合方法研究。
BMC Med Inform Decis Mak. 2024 Oct 12;24(1):302. doi: 10.1186/s12911-024-02696-9.
6
"Am I OK?" using human centered design to empower rheumatoid arthritis patients through patient reported outcomes.“我还好吗?”——通过患者报告结局,以人本主义设计赋能类风湿关节炎患者。
Patient Educ Couns. 2019 Mar;102(3):503-510. doi: 10.1016/j.pec.2018.10.016. Epub 2018 Oct 28.
7
Perception of Older Adults Toward Smartwatch Technology for Assessing Pain and Related Patient-Reported Outcomes: Pilot Study.老年人对用于评估疼痛和相关患者报告结局的智能手表技术的认知:初步研究。
JMIR Mhealth Uhealth. 2019 Mar 26;7(3):e10044. doi: 10.2196/10044.
8
Delay in seeking medical help in patients with rheumatoid arthritis in India: A qualitative study.印度类风湿关节炎患者寻求医疗帮助的延误:一项定性研究。
Int J Rheum Dis. 2020 Dec;23(12):1707-1718. doi: 10.1111/1756-185X.14001. Epub 2020 Oct 17.
9
"I want to know everything": a qualitative study of perspectives from patients with chronic diseases on sharing health information during hospitalization.“我想了解一切”:一项关于慢性病患者在住院期间分享健康信息观点的定性研究
BMC Health Serv Res. 2017 Aug 4;17(1):529. doi: 10.1186/s12913-017-2487-6.
10
Patient-Identified Barriers and Facilitators to Pre-Visit Patient-Reported Outcomes Measures Completion in Patients With Hip and Knee Pain.患者报告结局测量在髋膝关节疼痛患者中就诊前完成的患者识别障碍和促进因素。
J Arthroplasty. 2018 Mar;33(3):643-649.e1. doi: 10.1016/j.arth.2017.10.022. Epub 2017 Nov 21.

引用本文的文献

1
Patients with antiphospholipid antibodies preferentially seek health information from physicians: a cross-sectional online patient quantitative survey.抗磷脂抗体患者更倾向于从医生那里获取健康信息:一项横断面在线患者定量调查。
Rheumatol Int. 2025 Jan 24;45(2):37. doi: 10.1007/s00296-024-05777-0.
2
Barriers and facilitators to the uptake of electronic collection and use of patient-reported measures in routine care of older adults: a systematic review with qualitative evidence synthesis.老年人常规护理中采用患者报告测量的电子收集和使用的障碍与促进因素:一项基于定性证据综合的系统评价
JAMIA Open. 2024 Aug 2;7(3):ooae068. doi: 10.1093/jamiaopen/ooae068. eCollection 2024 Oct.
3

本文引用的文献

1
Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.使用患者报告结局测量信息系统(PROMIS)对类风湿关节炎的达标治疗(T2T)方法进行标准化和个性化:以患者为中心的治疗优先级的基线研究结果
Clin Rheumatol. 2017 Aug;36(8):1729-1736. doi: 10.1007/s10067-017-3731-5. Epub 2017 Jun 26.
2
Agreement of Ocular Symptom Reporting Between Patient-Reported Outcomes and Medical Records.患者报告结局与病历之间眼部症状报告的一致性
JAMA Ophthalmol. 2017 Mar 1;135(3):225-231. doi: 10.1001/jamaophthalmol.2016.5551.
3
Rheumatoid arthritis patients' perspective on the use of prediction models in clinical decision-making.
类风湿关节炎患者对预测模型在临床决策中应用的看法。
Rheumatology (Oxford). 2025 Mar 1;64(3):1045-1051. doi: 10.1093/rheumatology/keae202.
4
Patient and Public Willingness to Share Personal Health Data for Third-Party or Secondary Uses: Systematic Review.患者和公众对个人健康数据用于第三方或二次使用的意愿:系统评价。
J Med Internet Res. 2024 Mar 5;26:e50421. doi: 10.2196/50421.
5
Remote monitoring of patients with rheumatoid arthritis in a low disease activity state: a mixed methods evaluation across six hospitals in London, UK.英国伦敦六家医院的类风湿关节炎低疾病活动度患者远程监测:混合方法评估。
Rheumatology (Oxford). 2024 Oct 1;63(10):2721-2733. doi: 10.1093/rheumatology/keae112.
6
Peer Support in Rheumatic Diseases: A Narrative Literature Review.风湿性疾病中的同伴支持:一项叙述性文献综述
Patient Prefer Adherence. 2023 Oct 2;17:2433-2449. doi: 10.2147/PPA.S391396. eCollection 2023.
7
Artificial intelligence in diabetes management: Advancements, opportunities, and challenges.人工智能在糖尿病管理中的应用:进展、机遇与挑战。
Cell Rep Med. 2023 Oct 17;4(10):101213. doi: 10.1016/j.xcrm.2023.101213. Epub 2023 Oct 2.
8
Measuring the willingness to share personal health information: a systematic review.测量个人健康信息共享意愿:系统评价。
Front Public Health. 2023 Jul 20;11:1213615. doi: 10.3389/fpubh.2023.1213615. eCollection 2023.
9
Telemedicine in Rheumatoid Arthritis: A Review of the PubMed Literature.类风湿关节炎中的远程医疗:PubMed文献综述
Mediterr J Rheumatol. 2023 Mar 31;34(1):16-23. doi: 10.31138/mjr.34.1.16. eCollection 2023 Mar.
10
Virtual training of rheumatoid arthritis peer coaches in motivational interviewing skills and concepts of cardiovascular disease.类风湿关节炎同伴教练在动机性访谈技巧和心血管疾病概念方面的虚拟培训。
Contemp Clin Trials Commun. 2023 Apr 5;33:101130. doi: 10.1016/j.conctc.2023.101130. eCollection 2023 Jun.
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
2015年美国风湿病学会类风湿关节炎治疗指南
Arthritis Care Res (Hoboken). 2016 Jan;68(1):1-25. doi: 10.1002/acr.22783. Epub 2015 Nov 6.
4
High disease activity may not be sufficient to escalate care.高疾病活动度可能不足以升级治疗。
Arthritis Care Res (Hoboken). 2014 Feb;66(2):197-203. doi: 10.1002/acr.22098.
5
Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO study.医生报告的结局与患者报告的结局在类风湿关节炎改善病情抗风湿药强化治疗中的相对重要性:DUO 研究。
Rheumatology (Oxford). 2013 Feb;52(2):391-9. doi: 10.1093/rheumatology/kes285. Epub 2012 Oct 25.
6
Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study.托珠单抗治疗肿瘤坏死因子抑制剂治疗抵抗的类风湿关节炎患者的健康相关生活质量改善:来自 24 周随机对照 RADIATE 研究的结果。
Rheumatology (Oxford). 2012 Oct;51(10):1860-9. doi: 10.1093/rheumatology/kes131. Epub 2012 Jun 28.
7
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.2008年美国风湿病学会关于使用改善病情抗风湿药和生物制剂治疗类风湿关节炎的建议的2012年更新版。
Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641.
8
Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity.患者和医生对类风湿关节炎疾病活动评分不一致的决定因素。
Arthritis Care Res (Hoboken). 2012 Feb;64(2):206-14. doi: 10.1002/acr.20685.
9
Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.阿达木单抗治疗早期类风湿关节炎患者的健康相关生活质量结局:一项随机多中心研究的结果。
J Rheumatol. 2012 Jan;39(1):63-72. doi: 10.3899/jrheum.101161. Epub 2011 Nov 1.
10
Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large U.S. cohort.类风湿关节炎患者生物制剂转换的疾病活动度阈值:来自美国大型队列的经验。
Arthritis Care Res (Hoboken). 2011 Dec;63(12):1672-9. doi: 10.1002/acr.20643.